Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Pemamek announces German subsidiary opening: Oliver Decker to lead the sales

To reinforce its local presence and bring the services closer to its customers, Pemamek Ltd. has opened a daughter company in Germany. The official subsidiary, Pemamek GmbH, will be led by the newly hired sales director, Oliver Decker. Oliver Decker (in the photo) will be leading the subsidiary in Germany, Pemamek GmbH.  As a part of the global company strategy, Pemamek Ltd. has opened a daughter company, Pemamek GmbH, in Germany. The subsidiary, active since April 2021, is strategically located in the center of Germany, in Bad Arolsen. To lead the operations in Germany,

Notice to convene Annual General Meeting of DecideAct A/S

The Board of Directors hereby convenes the Annual General Meeting to be held on: Monday, 31 May 2021 at 15:00, Østre Kajgade 3, DK-3730 Nexø See attachments for full notice to convene and other relevant documents.DecideAct A/S [ACT] Company Announcement No. 13-2021 Measures due to COVID-19 In the light of the COVID-19 situation, all shareholders are urged - in the interests of everyone's safety and in order to reduce the risk of the spread of infection as far as possible - not to physically attend the general meeting. Shareholders will instead have the opportunity to

BioStock: Chordate Medical's CEO on CE marking in chronic migraine

Chordate Medical has received a CE marking for K.O.S for the treatment of chronic migraine, meaning that the product can now be sold and marketed within the EU. The CE marking, which is a very important milestone for the company, got approved one year earlier than projected. BioStock contacted Anders Weilandt, Chordate Medical’s CEO, to find out what the CE marking means for the company.Read the full article at biostock.se:https://www.biostock.se/en/chordate-medicals-ceo-on-ce-marking-in-chronic-migraine/This is a press release from BioStock - Connecting Innovation & Capital. https://

FluoGuide has received approval to commence with FG001 in evening dosing in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 12 May 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the Danish Medicines Agency and Ethical Committee has approved administration of FG001 in the evening before surgery.The data from the ongoing dose finding trial suggests that background light intensity might be further reduced if FG001 is administered in the evening prior to surgery. This would presumably give an even better image quality and tumor delineation. To ensure that the best possible combination of FG001 dose and time of administration is carried forward in clinical

IAR Systems extends product portfolio for streamlined Linux-based automated workflows

In addition to previous support for Arm, RISC-V, Renesas RH850 and Renesas RX, IAR Systems’ build tools for Linux are now available for Renesas RL78Uppsala, Sweden—May 12, 2021—IAR Systems®, the future-proof supplier of software tools and services for embedded development, today presented the latest addition to its powerful build tools for Linux, which are based on the well-known build tools in the development toolchain IAR Embedded Workbench®. The extended tools now support deployment in Linux-based frameworks for Renesas’ low-power RL78 microcontrollers (MCUs), enabling organizations to

IAR Systems extends product portfolio for streamlined Linux-based automated workflows

In addition to previous support for Arm, RISC-V, Renesas RH850 and Renesas RX, IAR Systems’ build tools for Linux are now available for Renesas RL78Stockholm, Sweden—May 12, 2021—IAR Systems, the future-proof supplier of software tools and services for embedded development, today presented the latest addition to its powerful build tools for Linux, which are based on the well-known build tools in the development toolchain IAR Embedded Workbench. The extended tools now support deployment in Linux-based frameworks for Renesas’ low-power RL78 microcontrollers (MCUs), enabling organizations to

SafeRunner to save more lives on Romanian beaches

The Romanian lifeguards in Constanta has a very important mission, to save lives on the local city beaches. They will now increase their capabilities with another SafeRunner system in addition to the two SafeRunner systems they have from before.The Romanan beaches are becoming more and more safe due to the fantastic work that the lifeguard organisation SALVAMAR EFORIE is performing. We are very proud that they have since last year selected our SafeRunner system for their operations and that the shift to using our boats instead of conventional jetskis has meant that they can now perform mass-

Electrolux invites the younger generation to explore solutions for a better living

Electrolux publishes an open letter to today’s youth, inviting them to join forces with the company and some of the most influential change-makers of today to explore solutions for future sustainable homes. The aim is to learn more about young people’s hopes, dreams and concerns, to be able to provide solutions tailored to their needs come 2030.As a part of realizing the company’s vision and bold 2030 targets for better and more sustainable living around the world, Electrolux invites today’s youth to join a team of change-makers – a collaboration between Electrolux, young minds from across

A kidney transplant made Edwin’s life-saving work very personal

Since his successful kidney transplant a year ago, being part of a team that delivers Life Science solutions to customers worldwide has become very personal for Getinge’s Edwin van der Ree. “Getinge’s Life Science solutions enable safe and efficient research and development of medicines and vaccines. Knowing that the anti-rejection medicines I take may have been developed in a safe and efficient way with the help of products like ours has for sure given my workdays a new dimension. It is easier to really identify with people who need medicines to live a healthy life,” Edwin says.

Changes in the Assemblin Board of Directors

At the Annual General Meeting on 11 May 2021 Per-Ingemar Persson was elected as new Board Member. Per-Ingemar Persson is replacing Leif Gustafsson, who has declined re-election. At the same time, Mats Wäppling (Chairman of the Board), Susanne Ekblom, Mats Jönsson, Young Kim and Anders Thulin were re-elected.For more information about the Board of Directors of Assemblin: https://www.assemblin.com/investors/corporate-governance/owner-and-board/ For further information, contact:  Chairman of the Board, Mats Wäppling, +46 (0)70-645 03 21 About Assemblin Assemblin is an end-to-end

Report of payments to government agencies in 2020

Boliden is today publishing its report of payments to government agencies in accordance with Swedish law (2015:812) on the reporting of payments to government agencies. The report encompasses payments made to government agencies in Sweden, Finland and Ireland that pertain to extractive industry operations in 2020. This information is information that Boliden AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 09.00 CET on 12 May 2021. For further information, please contact:Klas Nilsson, Director Group Communications,

Member of Immunovia’s Board of Directors purchases shares in the company

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) announced today that the member of the Board of Directors Peter Høngaard Andersen has almost doubled his ­­­­shareholding in Immunovia by purchasing 2,730 shares, an investment of 297,570 SEK. After the purchase, the holding amounts to 5,730 shares.   For more information, please contact:Patrik Dahlen, CEO ImmunoviaEmail: patrik.dahlen@immunovia.comTel: +46 73 376 76 64 About ImmunoviaImmunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and

Word Mansion passes one million downloads

The word puzzle game Word Mansion reaches a milestone and continues to show strong average revenue per user.Stockholm, Sweden - 12 May, 2021 - Today MAG Interactive announces that Word Mansion has passed one million downloads. The game is developed by the Swedish game studio Apprope, a company which MAG acquired in early January. Word Mansion is a word puzzle game framed by a story that revolves around renovation and decoration and was released for iOS and Android in the fall of 2020. Since its release, the game has grown significantly; by the end of March 2021 it reached high listings

Wärtsilä Cargo Handling and Fuel Supply Systems again selected for Oriental Energy vessels

Wärtsilä Corporation, Press release, 12 May 2021 at 10:00 AM EESTThe technology group Wärtsilä will supply the Cargo Handling and LPG Fuel Supply Systems for two new very large gas carrier vessels (VLGC) being built for China-based Oriental Energy, a company mainly focusing on operation of PDH (Propane Dehydrogenation) factories and LPG trading. The ships are under construction at the Jiangnan yard in China. The order with Wärtsilä was placed in April 2021. The 93,000 cbm capacity vessels are among the largest of their type ever built. In addition to the Cargo Handling System 

Storytel’s CFO ranked top 10 among Sweden’s young female executives

Sofie Zettergren is Storytel’s 35 year old CFO & Head of Business Administration.She is also one of Sweden’s top 10 young female executives on this year’s Female Leaders of the Future list – an official ranking presented by Sweden's professional organization for executives, Ledarna.For the 15th consecutive year, the Swedish organization Ledarna has presented The Female Leaders of the Future among industry leaders aged 20–35. The purpose of this initiative is to highlight executive role models, and emphasize the need for modern leadership and young women in leading positions.Sofie

Trophy Games enters the Chinese market with Pro 11

Trophy Games has signed a publishing deal with CrazySports to release the game title Pro 11 in China.The mobile gaming market in China is one of the largest and most lucrative with rapid growth rates every year.  Pro 11 will be launched in China in H2 2021 and it is expected to take some months to build a user base in the market before revenue kicks in fully in 2022. “This is a big breakthrough for Trophy Games. Our new partner CrazySports is a top-level sports game publisher and is the official partner of the Chinese Super League as well as NBA in China. We could not wish for a

Sentica has sold its shareholding in Solteq Plc

Stock Exchange Bulletin, May 12, 2021 at 09:55 a.m. According to a press release issued by Sentica Partners Oy (“Sentica”) today, the funds managed by Sentica, consisting of Sentica Buyout III Ky and Sentica Buyout III Co-Investment Ky, have sold all of their shareholdings in Solteq Plc (“Solteq”). Sentica has sold today a total of 4,801,293 shares in Solteq to a group of institutional investors at a price of EUR 4.70 per share. Sold shares represent about 24.75 percent of Solteq Plc's shares.   Distribution NASDAQ OMX HelsinkiKey mediawww.solteq.com 

G5 Entertainment has submitted its new free-to-play game Hidden Epee for review

G5 Entertainment has submitted its new free-to-play hidden object game Hidden Epee for review to the Apple App Store. The game will be limited to Russia. Hidden Epee is developed by Deep Shadows Games Limited and G5 acts as a publisher. In Hidden Epee, players embark on a mystery-filled mission to Paris during the Age of Enlightenment to help solve a series of unexplained eclipses that have fallen over the City. As players challenge their skills in unravelling hidden object scenes and unlocking new puzzles, they can enjoy the picturesque locations that reimagines life in 17[th] century

TORM plc First Quarter Report 2021

“In the first quarter of 2021, TORM achieved an EBITDA of USD 19m, in a market which continues to be impacted by the pandemic. Further I am pleased that we have just purchased three LR2 vessels on top of the eight MR vessels acquired earlier this year” says Executive Director Jacob Meldgaard. · In the first quarter of 2021, TORM achieved TCE rates of USD/day 13,493 (2020, same period: USD/day 23,642) and an EBITDA of USD 18.9m (2020, same period: USD 101.5m). The loss before tax amounted to USD -21.1m (2020, same period a profit of USD 56.8m), and earnings per share (EPS) was negative

PPG Industries, Inc. supplements the tender offer document dated January 14, 2021 relating to the voluntary recommended public cash tender offer for all the shares in Tikkurila Oyj

TIKKURILA OYJTender Offer May 12, 2021 at 9.37 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. PPG Industries, Inc. (“PPG” or the “Offeror”), a corporation incorporated under the laws of Pennsylvania, and Tikkurila Oyj (“Tikkurila” or the “Company”) have on December 18, 2020 entered into a combination agreement (the “Combination Agreement”), which was amended

Invitation to presentation of Sectra’s year-end report 2020/2021

Linköping, Sweden – May 12, 2021 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will publish its year-end report for the 2020/2021 fiscal year on June 2, 2021. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report.Publication of the year-end report: 8:15 a.m. (CEST) June 2, 2021 Presentation and audiocast: 10:00 a.m. (CEST) June 2, 2021 To participate, follow online at investor.sectra.com/q4report2021 or call one of the following numbers five to

NattoPharma releases Q1 2021 Trading Update

Oslo, Norway (12 May 2021) NattoPharma reports revenues of NOK 49.9 million for the quarter, a decrease of 11% compared to the same quarter last year. Underlying volumes decreased by 7%.  YTD Adjusted EBITDA came in at NOK 11.0 million, equal to a margin of 21.9%. Performance highlights for Q1 2021 (Q1 2020 in brackets) · Operating revenue of NOK 49.9m (NOK 56.3m) · Adjusted EBITDA of NOK 11.0m (NOK 10.5m) · Adjusted EBITDA margin of 21.9% (18.7%) · Our supply situation, including Natural supply from India, is flowing as normal, with no current delays despite COVID-

There are no items matching the current filter
There are no more items matching the current filter
Back to top